INTAS is proud to contribute with Latin American countries by launching qualitative generics for a better access to essential and affordable medicines.
LATAM offered an early launch opportunity so INTAS developed a complete dossier adapted to all geographies.
We have already obtained the marketing authorization for our Rivaroxaban in Chile and Ecuador and we are working closely with our partners to ensure a successful DAY ONE Launch!
